MoleculeMind
Haidian
About MoleculeMind
MoleculeMind is an AI protein design platform company. It will bring changes to the discovery, optimization, and design of proteins through AI algorithms to accelerate the entire process of drug development and promote all fields such as industrial and agricultural production, material design, and environmental improvement.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $28.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: moleculemind.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/moleculemind-55026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.